Perrone MG - Search Results

1

An attempt to chemically state the cross-talk between monomers of COX homodimers by double/hybrid inhibitors mofezolac-spacer-mofezolac and mofezolac-spacer-arachidonic acid.

Perrone MG, Miciaccia M, Vitale P, Ferorelli S, Araújo CDCB, de Almeida GS, Souza Domingos TF, da Silva LCRP, de Pádula M, Cabral LM, Sathler PC, Bonaccorso C, Fortuna CG, Scilimati A. Perrone MG, et al. Eur J Med Chem. 2021 Jan 1;209:112919. doi: 10.1016/j.ejmech.2020.112919. Epub 2020 Oct 9. Eur J Med Chem. 2021. PMID: 33129592

2

Synthesis and biological evaluation of new clofibrate analogues as potential PPARalpha agonists.

Perrone MG, Santandrea E, Dell'Uomo N, Giannessi F, Milazzo FM, Sciarroni AF, Scilimati A, Tortorella V. Perrone MG, et al. Eur J Med Chem. 2005 Feb;40(2):143-54. doi: 10.1016/j.ejmech.2004.09.018. Eur J Med Chem. 2005. PMID: 15694649

3

A chemoenzymatic scalable route to optically active (R)-1-(pyridin-3-yl)-2-aminoethanol, valuable moiety of beta3-adrenergic receptor agonists.

Perrone MG, Santandrea E, Giorgio E, Bleve L, Scilimati A, Tortorella P. Perrone MG, et al. Bioorg Med Chem. 2006 Feb 15;14(4):1207-14. doi: 10.1016/j.bmc.2005.09.046. Epub 2005 Oct 10. Bioorg Med Chem. 2006. PMID: 16216512

4

Stereospecific synthesis and bio-activity of novel beta(3)-adrenoceptor agonists and inverse agonists.

Perrone MG, Santandrea E, Bleve L, Vitale P, Colabufo NA, Jockers R, Milazzo FM, Sciarroni AF, Scilimati A. Perrone MG, et al. Bioorg Med Chem. 2008 Mar 1;16(5):2473-88. doi: 10.1016/j.bmc.2007.11.060. Epub 2007 Nov 28. Bioorg Med Chem. 2008. PMID: 18083578

5

Upregulation of beta3-adrenergic receptor mRNA in human colon cancer: a preliminary study.

Perrone MG, Notarnicola M, Caruso MG, Tutino V, Scilimati A. Perrone MG, et al. Oncology. 2008;75(3-4):224-9. doi: 10.1159/000163851. Epub 2008 Oct 14. Oncology. 2008. PMID: 18852493

6

The tertiary amine nitrogen atom of piperazine sulfonamides as a novel determinant of potent and selective beta3-adrenoceptor agonists.

Perrone MG, Bleve L, Santandrea E, Vitale P, Niso M, Scilimati A. Perrone MG, et al. ChemMedChem. 2009 Dec;4(12):2080-97. doi: 10.1002/cmdc.200900292. ChemMedChem. 2009. PMID: 19882697

7

Selective COX-1 inhibition: A therapeutic target to be reconsidered.

Perrone MG, Scilimati A, Simone L, Vitale P. Perrone MG, et al. Curr Med Chem. 2010;17(32):3769-805. doi: 10.2174/092986710793205408. Curr Med Chem. 2010. PMID: 20858219 Review.

8

β(3)-Adrenoceptor ligand development history through patent review.

Perrone MG, Scilimati A. Perrone MG, et al. Expert Opin Ther Pat. 2011 Apr;21(4):505-36. doi: 10.1517/13543776.2011.561316. Epub 2011 Mar 17. Expert Opin Ther Pat. 2011. PMID: 21410429 Review.

9

Novel selective COX-1 inhibitors suppress neuroinflammatory mediators in LPS-stimulated N13 microglial cells.

Calvello R, Panaro MA, Carbone ML, Cianciulli A, Perrone MG, Vitale P, Malerba P, Scilimati A. Calvello R, et al. Among authors: perrone mg. Pharmacol Res. 2012 Jan;65(1):137-48. doi: 10.1016/j.phrs.2011.09.009. Epub 2011 Oct 1. Pharmacol Res. 2012. PMID: 22001217

10

Synthesis and toxicopharmacological evaluation of m-hydroxymexiletine, the first metabolite of mexiletine more potent than the parent compound on voltage-gated sodium channels.

Catalano A, Desaphy JF, Lentini G, Carocci A, Di Mola A, Bruno C, Carbonara R, De Palma A, Budriesi R, Ghelardini C, Perrone MG, Colabufo NA, Conte Camerino D, Franchini C. Catalano A, et al. Among authors: perrone mg. J Med Chem. 2012 Feb 9;55(3):1418-22. doi: 10.1021/jm201197z. Epub 2012 Jan 31. J Med Chem. 2012. PMID: 22191686

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page